Show simple item record  

dc.contributor.authorBlackmore, Tania Louiseen_NZ
dc.contributor.authorLao, Chunhuanen_NZ
dc.contributor.authorChepulis, Lynne Merranen_NZ
dc.contributor.authorPage, Blaithinen_NZ
dc.contributor.authorLawrenson, Rossen_NZ
dc.coverage.spatialNew Zealanden_NZ
dc.date.accessioned2020-09-14T02:26:43Z
dc.date.available2020-09-14T02:26:43Z
dc.date.issued2020en_NZ
dc.identifier.citationBlackmore, T., Lao, C., Chepulis, L. M., Page, B., & Lawrenson, R. (2020). The characteristics and outcomes of patients with colorectal cancer in New Zealand, analysed by Cancer Network. New Zealand Medical Journal, 133(1513), 42–52.en
dc.identifier.urihttps://hdl.handle.net/10289/13822
dc.description.abstractAIM: The incidence of colorectal cancer (CRC) in New Zealand is high by international standards. Approximately 1,200 people in New Zealand die from this disease per year. Outcomes in New Zealand following a CRC diagnosis are poor. We aimed to describe the characteristics and outcomes of patients diagnosed with CRC across the four regional cancer networks in New Zealand. METHOD: Patient demographics, tumour characteristics and survival outcomes for all patients diagnosed with CRC between 2006 and 2015 were analysed retrospectively from the National Cancer Registry (NZCR) and National Mortality collection and were linked by National Health Index (NHI) number. RESULTS: A total of 29,221 CRC cases were recorded during the 10-year study period, of which the majority were cancer of the colon (67.9%). In this sample, 42.0% were >75 years, 52.1% were male and 88.1% were New Zealand European. After adjustment for factors such as age, gender, ethnicity year of diagnosis, cancer extent, cancer grade, lymph node and cancer site, cancer-related and all-cause survival were not significantly different by cancer network for those aged <75 but for patients aged >75 years, those living in the Central and Midland Cancer Network had a higher risk of dying of CRC compared to those in the Northern Cancer Network (1.12, 95% CI: 1.03-1.22 and 1.10, 95% CI: 1.02-1.18 respectively). Overall, Māori and Pacific people had worse cancer-specific and all-cause survival than New Zealand European. CONCLUSION: No regional variations were seen within New Zealand for the characteristics and survival outcomes of patients <75 diagnosed with CRC. The risk of dying from CRC increased for those >75, which is supportive of the international literature regarding outcomes for the elderly and CRC. We continue to show disparity in outcomes for Māori and Pacific patients diagnosed with CRC in New Zealand.en_NZ
dc.format.mimetypeapplication/pdf
dc.language.isoenen_NZ
dc.publisherNew Zealand Medical Association
dc.relation.urihttps://www.nzma.org.nz/journal
dc.rightsThis article is published in the New Zealand Medical Journal. © NZMA. Used with permission.
dc.subjectAgeden_NZ
dc.subjectAged, 80 and overen_NZ
dc.subjectColorectal Neoplasmsen_NZ
dc.subjectFemaleen_NZ
dc.subjectHumansen_NZ
dc.subjectMaleen_NZ
dc.subjectMiddle Ageden_NZ
dc.subjectNew Zealanden_NZ
dc.subjectRetrospective Studiesen_NZ
dc.titleThe characteristics and outcomes of patients with colorectal cancer in New Zealand, analysed by Cancer Network.en_NZ
dc.typeJournal Article
dc.relation.isPartOfNew Zealand Medical Journalen_NZ
pubs.begin-page42
pubs.elements-id252726
pubs.end-page52
pubs.issue1513en_NZ
pubs.publication-statusPublished onlineen_NZ
pubs.volume133en_NZ
dc.identifier.eissn1175-8716en_NZ


Files in this item

This item appears in the following Collection(s)

Show simple item record